Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on: July 18,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on:July 18,2026

Cancer vaccine sustains 49% melanoma reduction after 5 years

byNYU Langone HealthCredit: CC0 Public DomainThe combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin can

Updated on: August 16,2026

Cancer vaccine sustains 49% melanoma reduction after 5 years

byNYU Langone HealthCredit: CC0 Public DomainThe combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin can

Updated on:August 16,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on: July 28,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on:July 28,2026

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on: August 02,2026

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on:August 02,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on: August 10,2026

GLP-1 use linked to lower breast cancer incidence in large cohort study

byPerelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who

Updated on:August 10,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on: August 11,2026

Experimental drug combination shows early effectiveness in advanced kidney cancer

by Brittany Cordeiro,Mayo ClinicCredit: Unsplash/CC0 Public DomainAn experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a f

Updated on:August 11,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on: August 06,2026

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainPreviously, immature overall survival results of the NRG Oncology GY018 (NRG-GY018) trial suggested that the use of the immunotherapy drug pembrolizumab

Updated on:August 06,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on: July 27,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on:July 27,2026

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Updated on: August 02,2026

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Updated on:August 02,2026

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul

Updated on: July 31,2026

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul

Updated on:July 31,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on: August 08,2026

New targeted combination in people with relapsed acute myeloid leukemia shows promise

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainNew research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational tre

Updated on:August 08,2026

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome

Updated on: August 20,2026

Long-hidden 'junk DNA' regions may help explain cancer-linked genome instability

byUniversity of BarcelonaGenomic organization and regulatory biology of SST1/NBL2 macrosatellites. Credit:Trends in Genetics(2026). DOI: 10.1016/j.tig.2026.03.004Many repetitive regions of the genome

Updated on:August 20,2026